{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:24:38Z","timestamp":1795109078803,"version":"4.10.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071373"],"award-info":[{"award-number":["81071373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271857"],"award-info":[{"award-number":["81271857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011136","name":"State Key Laboratory of Veterinary Etiological Biology","doi-asserted-by":"crossref","award":["SKLVEB2011KFKT005"],"award-info":[{"award-number":["SKLVEB2011KFKT005"]}],"id":[{"id":"10.13039\/501100011136","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2009CM079"],"award-info":[{"award-number":["ZR2009CM079"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-016-2104-z","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T23:36:49Z","timestamp":1484091409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB\/c mice"],"prefix":"10.1186","volume":"17","author":[{"given":"Yali","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"issue":"6","key":"2104_CR1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","volume":"55","author":"JP Dubey","year":"2008","unstructured":"Dubey JP. The history of Toxoplasma gondii--the first 100\u00a0years. J Eukaryot Microbiol. 2008;55(6):467\u201375.","journal-title":"J Eukaryot Microbiol"},{"issue":"7","key":"2104_CR2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/fpd.2010.0795","volume":"8","author":"BT Cenci-Goga","year":"2011","unstructured":"Cenci-Goga BT, Rossitto PV, Sechi P, McCrindle CM, Cullor JS. Toxoplasma in animals, food, and humans: an old parasite of new concern. Foodborne Pathog Dis. 2011;8(7):751\u201362.","journal-title":"Foodborne Pathog Dis"},{"issue":"9425","key":"2104_CR3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965\u201376. 3.","journal-title":"Lancet"},{"issue":"2","key":"2104_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","volume":"11","author":"JP Dubey","year":"1998","unstructured":"Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 1998;11(2):267\u201399.","journal-title":"Clin Microbiol Rev"},{"key":"2104_CR5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/1471-2334-13-494","volume":"13","author":"M Meng","year":"2013","unstructured":"Meng M, Zhou A, Lu G, Wang L, Zhao G, Han Y, et al. DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB\/c mice. BMC Infect Dis. 2013;13:494. 5.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2104_CR6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","volume":"104","author":"E Jongert","year":"2009","unstructured":"Jongert E, Roberts CW, Gargano N, F\u00f6rster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii:challenges and opportunities. Mem Inst Oswaldo Cruz. 2009;104(2):252\u201366.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"2104_CR7","first-page":"125","volume":"55","author":"E Hiszczy\u0144ska-Sawicka","year":"2009","unstructured":"Hiszczy\u0144ska-Sawicka E, Holec-Gasior L, Kur J. DNA vaccines and recombinant antigens in prevention of Toxoplasma gondii infections-current status of the studies. Wiad Parazytol. 2009;55(2):125\u201339.","journal-title":"Wiad Parazytol"},{"issue":"15","key":"2104_CR8","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3748\/wjg.v12.i15.2363","volume":"12","author":"KY Liu","year":"2006","unstructured":"Liu KY, Zhang DB, Wei QK, Li J, Li GP, Yu JZ. Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol. 2006;12(15):2363\u20138.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2104_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2003.11.016","volume":"91","author":"K Kim","year":"2004","unstructured":"Kim K. Role of proteases in host cell invasion by Toxoplasma gondii and other Apicomplexa. Acta Trop. 2004;91(1):69\u201381.","journal-title":"Acta Trop"},{"issue":"712","key":"2104_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4419-8414-2_4","volume":"2011","author":"Z Dou","year":"2011","unstructured":"Dou Z, Carruthers VB. Cathepsin proteases in Toxoplasma gondii. Adv Exp Med Biol. 2011;2011(712):49\u201361.","journal-title":"Adv Exp Med Biol"},{"key":"2104_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-13-207","volume":"13","author":"G Zhao","year":"2013","unstructured":"Zhao G, Zhou A, Lv G, Meng M, Sun M, Bai Y, et al. Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis. BMC Infect Dis. 2013;13:207.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"2104_CR12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijpara.2005.04.001","volume":"35","author":"TJ Dowse","year":"2005","unstructured":"Dowse TJ, Pascall JC, Brown KD, Soldati D. Apicomplexan rhomboids have a potential role in microneme protein cleavage during host cell invasion. Int J Parasitol. 2005;35(7):747\u201356.","journal-title":"Int J Parasitol"},{"issue":"11","key":"2104_CR13","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1073\/pnas.0407918102","volume":"102","author":"F Brossier","year":"2005","unstructured":"Brossier F, Jewett TJ, Sibley LD, Urban S. A spatially localized rhomboid protease cleaves cell surface adhesins essential for invasion by Toxoplasma. Proc Natl Acad Sci U S A. 2005;102(11):4146\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2104_CR14","doi-asserted-by":"crossref","first-page":"e1000858","DOI":"10.1371\/journal.ppat.1000858","volume":"6","author":"JS Buguliskis","year":"2010","unstructured":"Buguliskis JS, Brossier F, Shuman J, Sibley LD. Rhomboid 4 (ROM4) affects the processing of surface adhesins and facilitates host cell invasion by Toxoplasma gondii. PLoS Pathog. 2010;6(4):e1000858.","journal-title":"PLoS Pathog"},{"issue":"5","key":"2104_CR15","doi-asserted-by":"crossref","first-page":"e01795","DOI":"10.1128\/mBio.01795-14","volume":"5","author":"B Shen","year":"2014","unstructured":"Shen B, Buguliskis JS, Lee TD, Sibley LD. Functional analysis of rhomboid proteases during Toxoplasma invasion. MBio. 2014;5(5):e01795\u201314.","journal-title":"MBio"},{"issue":"2","key":"2104_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/mmi.13021","volume":"97","author":"G Rugarabamu","year":"2015","unstructured":"Rugarabamu G, Marq JB, Gu\u00e9rin A, Lebrun M, Soldati-Favre D. Distinct contribution of Toxoplasma gondii rhomboid proteases 4 and 5 to micronemal protein protease 1 activity during invasion. Mol Microbiol. 2015;97(2):244\u201362.","journal-title":"Mol Microbiol"},{"issue":"2\u20134","key":"2104_CR17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vetpar.2011.08.014","volume":"184","author":"J Li","year":"2012","unstructured":"Li J, Han Q, Gong P, Yang T, Ren B, Li S, Zhang X. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis. Vet Parasitol. 2012;184(2\u20134):154\u201360.","journal-title":"Vet Parasitol"},{"key":"2104_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-7580-4-1","volume":"4","author":"J Sollner","year":"2008","unstructured":"Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, Mayer B. Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins. Immunome Res. 2008;4:1.","journal-title":"Immunome Res"},{"issue":"1\u20132","key":"2104_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.vetmic.2009.07.011","volume":"140","author":"ZW Zhang","year":"2010","unstructured":"Zhang ZW, Zhang YG, Wang YL, Pan L, Fang YZ, Jiang ST, et al. Screening and identification of B cell epitopes of structural proteins of foot-and-mouth disease virus serotype Asia I. Vet Microbiol. 2010;140(1\u20132):25\u201333.","journal-title":"Vet Microbiol"},{"issue":"6","key":"2104_CR20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.68.6.793","volume":"68","author":"DJ Shedlock","year":"2000","unstructured":"Shedlock DJ, Weiner DB. DNA vaccination: antigen presentation and the induction of immunity. J Leukoc Biol. 2000;68(6):793\u2013806.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"2104_CR21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4161\/hv.21006","volume":"8","author":"Q Liu","year":"2012","unstructured":"Liu Q, Singla LD, Zhou H. Vaccines against Toxoplasma gondii: status, challenges and future directions. Hum Vaccin Immunother. 2012;8(9):1305\u20138.","journal-title":"Hum Vaccin Immunother"},{"key":"2104_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-0556-7-7","volume":"7","author":"E Alekseeva","year":"2009","unstructured":"Alekseeva E, Sominskaya I, Skrastina D, Egorova I, Starodubova E, Kushners E, et al. Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. Genet Vaccines Ther. 2009;7:7.","journal-title":"Genet Vaccines Ther"},{"issue":"Pt 10","key":"2104_CR23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1017\/S0031182007002892","volume":"134","author":"G Zhang","year":"2007","unstructured":"Zhang G, Huong VT, Battur B, Zhou J, Zhang H, Liao M, et al. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice. Parasitology. 2007;134(Pt 10):1339\u201346.","journal-title":"Parasitology"},{"issue":"38","key":"2104_CR24","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.vaccine.2012.06.081","volume":"30","author":"J Min","year":"2012","unstructured":"Min J, Qu D, Li C, Song X, Zhao Q, Li XA, et al. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy. Vaccine. 2012;30(38):5631\u20136.","journal-title":"Vaccine"},{"issue":"47","key":"2104_CR25","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/j.vaccine.2011.09.016","volume":"29","author":"Y Wang","year":"2011","unstructured":"Wang Y, Wang M, Wang G, Pang A, Fu B, Yin H, et al. Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens. Vaccine. 2011;29(47):8619\u201323.","journal-title":"Vaccine"},{"issue":"11","key":"2104_CR26","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1128\/IAI.00533-10","volume":"78","author":"B Mahajan","year":"2010","unstructured":"Mahajan B, Berzofsky JA, Boykins RA, Majam V, Zheng H, Chattopadhyay R, et al. Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect Immun. 2010;78(11):4613\u201324.","journal-title":"Infect Immun"},{"key":"2104_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-59745-450-6_1","volume":"524","author":"MH Regenmortel Van","year":"2009","unstructured":"Van Regenmortel MH. What is a B-cell epitope? Methods Mol Biol. 2009;524:3\u201320.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"2104_CR28","doi-asserted-by":"crossref","first-page":"e40104","DOI":"10.1371\/journal.pone.0040104","volume":"7","author":"J Gao","year":"2012","unstructured":"Gao J, Faraggi E, Zhou Y, Ruan J, Kurgan L. BEST: improved prediction of B-cell epitopes from antigen sequences. PLoS One. 2012;7(6):e40104.","journal-title":"PLoS One"},{"issue":"1","key":"2104_CR29","first-page":"17","volume":"41","author":"IM El-Kady","year":"2011","unstructured":"El-Kady IM. T-cell immunity in human chronic toxoplasmosis. J Egypt Soc Parasitol. 2011;41(1):17\u201328.","journal-title":"J Egypt Soc Parasitol"},{"issue":"2","key":"2104_CR30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4049\/jimmunol.148.2.568","volume":"148","author":"JA Langermans","year":"1992","unstructured":"Langermans JA, Van der Hulst ME, Nibbering PH, Hiemstra PS, Fransen L, Van Furth R. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol. 1992;148(2):568\u201374.","journal-title":"J Immunol"},{"issue":"1","key":"2104_CR31","first-page":"71","volume":"40","author":"D Filisetti","year":"2004","unstructured":"Filisetti D, Candolfi E. Immune response to Toxoplasma gondii. Ann Ist Super Sanita. 2004;40(1):71\u201380.","journal-title":"Ann Ist Super Sanita"},{"issue":"5","key":"2104_CR32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2009.10.001","volume":"31","author":"G Oldenhove","year":"2009","unstructured":"Oldenhove G, et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity. 2009;31(5):772\u201386.","journal-title":"Immunity"},{"issue":"41","key":"2104_CR33","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","volume":"31","author":"B Zheng","year":"2013","unstructured":"Zheng B, Lu S, Tong Q, Kong Q, Lou D. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine. 2013;31(41):4578\u201384.","journal-title":"Vaccine"},{"issue":"2","key":"2104_CR34","first-page":"798","volume":"157","author":"RT Gazzinelli","year":"1996","unstructured":"Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, K\u00fchn R, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12. IFN-gamma and TNF-alpha J Immunol. 1996;157(2):798\u2013805.","journal-title":"IFN-gamma and TNF-alpha J Immunol"},{"issue":"2","key":"2104_CR35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.73.2.1116-1128.2005","volume":"73","author":"HD Dawson","year":"2005","unstructured":"Dawson HD, Beshah E, Nishi S, Solano-Aguilar G, Morimoto M, Zhao A, et al. Localized multigene expression patterns support an evolving Th1\/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum. Infect Immun. 2005;73(2):1116\u201328.","journal-title":"Infect Immun"},{"issue":"5","key":"2104_CR36","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","volume":"164","author":"H Kang","year":"2000","unstructured":"Kang H, Remington JS, Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol. 2000;164(5):2629\u201334.","journal-title":"J Immunol"},{"issue":"3","key":"2104_CR37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","volume":"68","author":"PC Sayles","year":"2000","unstructured":"Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun. 2000;68(3):1026\u201333.","journal-title":"Infect Immun"},{"issue":"9","key":"2104_CR38","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1586\/14760584.2015.1061938","volume":"14","author":"NZ Zhang","year":"2015","unstructured":"Zhang NZ, Xu Y, Wang M, Petersen E, Chen J, Huang SY, et al. Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines. 2015;14(9):1289\u201397.","journal-title":"Expert Rev Vaccines"},{"key":"2104_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1756-3305-6-175","volume":"6","author":"G Zhao","year":"2013","unstructured":"Zhao G, Zhou A, Lu G, Meng M, Sun M, Bai Y, et al. Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis. Parasit Vectors. 2013;6:175.","journal-title":"Parasit Vectors"},{"issue":"1\u20132","key":"2104_CR40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2012.09.008","volume":"254","author":"D Lambracht-Washington","year":"2013","unstructured":"Lambracht-Washington D, Qu BX, Fu M, Anderson Jr LD, Eagar TN, Stuve O, et al. A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Abeta42 DNA vaccine for Alzheimer disease. J Neuroimmunol. 2013;254(1\u20132):63\u20138.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2104_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00262-004-0576-y","volume":"54","author":"MJ Ciesielski","year":"2005","unstructured":"Ciesielski MJ, Kazim AL, Barth RF, Fenstermaker RA. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Cancer Immunol Immunother. 2005;54(2):107\u201319.","journal-title":"Cancer Immunol Immunother"},{"key":"2104_CR42","doi-asserted-by":"crossref","unstructured":"Woodland DL. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol.2004; 25(2):98-104","DOI":"10.1016\/j.it.2003.11.009"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-2104-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:44:33Z","timestamp":1692625473000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-2104-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-2104-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]},"article-number":"59"}}